Suppr超能文献

人促黄体生成素受体羧基末端半胱氨酸残基的棕榈酰化调节内吞后加工的证据。

Evidence that palmitoylation of carboxyl terminus cysteine residues of the human luteinizing hormone receptor regulates postendocytic processing.

作者信息

Munshi Utpal M, Clouser Christine L, Peegel Helle, Menon K M J

机构信息

Department of Biological Chemistry, University of Michigan Medical School, Ann Arbor, Michigan 48109-0617, USA.

出版信息

Mol Endocrinol. 2005 Mar;19(3):749-58. doi: 10.1210/me.2004-0335. Epub 2004 Nov 11.

Abstract

Palmitoylation is a well-conserved posttranslational modification among members of the G protein-coupled receptor superfamily. The present study examined the role of palmitoylation in endocytosis and postendocytic trafficking of the human LH receptor (LHR). Palmitoylation of the LHR was determined by incorporation of [3H]palmitic acid into wild-type (WT) or mutant receptor in which the potential palmitoylation sites, C643 and C644, were mutated to glycine residues. The WT receptor showed incorporation of [3H]palmitic acid into the mature 90-kDa form of the receptor whereas mutation of the two Cys residues abrogated this incorporation, indicating that Cys 643 and C644 are the sites of palmitoylation. The role of palmitoylation on endocytosis and postendocytic processing was examined by testing the ability of the WT and mutant receptor to undergo internalization, recycling, and lysosomal degradation. Compared with the WT receptor, the mutant receptor showed increased internalization and decreased recycling, suggesting that retention of palmitic acid residues at Cys 643 and 644 promotes LHR recycling. The role of palmitoylation on receptor recycling was substantiated by demonstrating that a different mutant, D578H LHR, which is deficient in palmitoylation, also recycled less efficiently. Furthermore, the data show that palmitoylation, not the rate of internalization, determines the efficiency of recycling. The present study shows that palmitoylation of cysteine residues 643 and 644 of the human LHR is a determinant of recycling.

摘要

棕榈酰化是G蛋白偶联受体超家族成员中一种保守性良好的翻译后修饰。本研究检测了棕榈酰化在人促黄体生成素受体(LHR)的内吞作用和内吞后转运中的作用。通过将[3H]棕榈酸掺入野生型(WT)或潜在棕榈酰化位点C643和C644突变为甘氨酸残基的突变型受体中来确定LHR的棕榈酰化。WT受体显示[3H]棕榈酸掺入到90 kDa的成熟受体形式中,而两个半胱氨酸残基的突变消除了这种掺入,表明Cys 643和C644是棕榈酰化位点。通过测试WT和突变型受体进行内化、再循环和溶酶体降解的能力,研究了棕榈酰化在内吞作用和内吞后加工中的作用。与WT受体相比,突变型受体显示内化增加而再循环减少,这表明Cys 643和644处棕榈酸残基的保留促进了LHR的再循环。通过证明另一种缺乏棕榈酰化的突变体D578H LHR再循环效率也较低,证实了棕榈酰化在受体再循环中的作用。此外,数据表明,决定再循环效率的是棕榈酰化,而不是内化速率。本研究表明,人LHR的半胱氨酸残基643和644的棕榈酰化是再循环的一个决定因素。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验